[1033 primo-implantations of cardiac pacemakers. Comparative advantages and disadvantages of epigastric and endocavitary approaches].
D000005:Abdomen / Q000601:surgery; D000368:Aged; D006328:Cardiac Catheterization / Q000009:adverse effects; D006348:Cardiac Surgical Procedures / Q000401:mortality; D004567:Electrodes, Implanted; D005260:Female; D006406:Hematoma / Q000209:etiology; D006429:Hemiplegia / Q000209:etiology; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000009:adverse effects; D010493:Pericarditis / Q000209:etiology; D010998:Pleurisy / Q000209:etiology; D011655:Pulmonary Embolism / Q000209:etiology; D018805:Sepsis / Q000209:etiology; D013223:Statistics as Topic; D013249:Sternum
A propos de 1033 primo-implantations de stimulateurs cardiaques. Avantages et inconvénients comparés de la voie épigastrique et de la voie endocavitaire